Healthcare Businesswomen’s Association Appoints Mary Stutts as Chief Executive Officer
Mary Stutts Becomes HBA’s First Woman of Color CEO
Incoming HBA CEO Prioritizes Preparing Women for C-Suite and Corporate Board Roles and Advancing Global...
Effective Pharma Ad Types & Stats
Pharmaceutical advertising is a crucial aspect of promoting and marketing drugs to the public. With the increase in competition, it has become essential for...
Building a Strong Brand Identity in the Pharmaceutical Industry: A Guide to Success
In the highly competitive pharmaceutical industry, creating a strong brand identity can set companies apart and help them connect with their target audience. A...
The Use of Big Data in Pharmaceutical Marketing: Opportunities and Challenges
Big data has become an increasingly important tool for businesses across various industries, and the pharmaceutical industry is no exception. With the advent of...
The Implications of a Cookieless Future and What it Means for Pharma Marketers in...
The world of digital marketing is rapidly evolving and the rise of privacy concerns is leading to a cookieless future. In recent years, consumers...
An Overview of the FDA’s Approval of Alzheimer’s Drug Leqembi
The Food and Drug Administration (FDA) has recently approved a new drug for the treatment of Alzheimer's disease called Leqembi. This approval marks a...
Effective Pharma Ad Types & Stats
Pharmaceutical advertising is a crucial aspect of promoting and marketing drugs to the public. With the increase in competition, it has become essential for...
Pharma’s Breakthrough with Alzheimer’s Disease and What the Future Looks Like
Pharmaceutical companies have made major strides in developing new treatments for Alzheimer's disease, offering hope for the millions of people affected by this debilitating...
The Change in Pharmaceutical Conferences Post Covid-19
Healthcare conferences have undergone significant changes since 2020 due to the COVID-19 pandemic. Prior to the pandemic, healthcare conferences were typically large in-person events,...
An Overview of the FDA’s Approval of Alzheimer’s Drug Leqembi
The Food and Drug Administration (FDA) has recently approved a new drug for the treatment of Alzheimer's disease called Leqembi. This approval marks a...
